¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"rapid lysis mutant"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cold adapted mutant
    Àú¿ÂÀûÀÀµ¹¿¬º¯ÀÌÁÖ
  • conditional lethal mutant
    Á¶°ÇÄ¡»çµ¹¿¬º¯ÀÌÁÖ
  • deletion mutant
    °á¼Õµ¹¿¬º¯ÀÌÁÖ
  • host-range mutant
    ¼÷ÁÖ¹üÀ§µ¹¿¬º¯ÀÌÁÖ
  • morphological mutant
    Çüŵ¹¿¬º¯ÀÌÁÖ
  • mutant
    1. µ¹¿¬º¯ÀÌ- 2. µ¹¿¬º¯ÀÌÁÖ, µ¹¿¬º¯ÀÌü
  • mutant frequency
    µ¹¿¬º¯ÀÌÁÖºóµµ
  • mutant gene
    µ¹¿¬º¯ÀÌÀ¯ÀüÀÚ
  • temperature-sensitive mutant
    ¿Âµµ¹Î°¨µ¹¿¬º¯ÀÌÁÖ
  • virulent mutant
    µ¶¼ºµ¹¿¬º¯ÀÌÁÖ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • biochemical mutant
    »ýÈ­ÇÐÀûµ¹¿¬º¯ÀÌü, »ýÈ­ÇÐÀûº¯ÀÌÁ¾
  • cold adapted mutant
    Àú¿ÂÀûÀÀµ¹¿¬º¯ÀÌü
  • conditional lethal mutant
    Á¶°ÇÄ¡»çµ¹¿¬º¯ÀÌÁÖ
  • deletion mutant
    °á¼ÕÇüµ¹¿¬º¯ÀÌÁÖ
  • mutant frequency
    µ¹¿¬º¯ÀÌüºóµµ
  • mutant gene
    µ¹¿¬º¯ÀÌÀ¯ÀüÀÚ
  • host-range mutant
    ¼÷ÁÖ¹üÀ§º¯ÀÌÁÖ, ¼÷ÁÖ¿ªµ¹¿¬º¯ÀÌü
  • mutant
    µ¹¿¬º¯ÀÌ-, µ¹¿¬º¯ÀÌÁÖ
  • morphological mutant
    Çüź¯À̱Õ
  • mutant species
    µ¹¿¬º¯ÀÌÁ¾
  • nutritional mutant
    ¿µ¾çº¯ÀÌÁÖ
  • temperature-sensitive mutant
    ¿Âµµ¹Î°¨µ¹¿¬º¯ÀÌÁÖ
  • virulent mutant
    µ¶¼ºµ¹¿¬º¯ÀÌÁÖ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • rapid eye movement
    ½Å¼Ó¾È±¸¿îµ¿.
  • rapid eye movement=REM
    ±Þ¼Ó¾È±¸¿îµ¿
  • rapid eye movements
    ±Þ¼Ó¾È¿îµ¿
  • rapid fiber
    ¼Ó¼¶À¯(áÜàéë«).
  • rapid filling wave
    ±Þ¼ÓÃæ¸¸ÆÄ.
  • rapid filtration
    ±Þ¼Ó°Å¸£±â.
  • rapid grower
    ½Å¼Ó¹ßÀ°±Õ(ãöáÜÛ¡ëÀж).
  • rapid induction
    ±Þ¼ÓµµÀÔ, ½Å¼Ó¸¶ÃëÀ¯µµ.
  • rapid injection
    ±Þ¼ÓÁÖÀÔ
  • rapid muscle
    ¼Ó±Ù(áÜÐÉ).
  • rapid neuroleptization
    ±Þ¼Ó ½Å°æÀÌ¿ÏÈ­(ãêÌèì¬èÐûù)
  • rapid pacing
    °í¼ÓÁ¶À².
  • rapid plaslma reagin test
    ½Å¼ÓÇ÷À帮¾ÆÁø½ÃÇè
  • rapid plasma reagin card test
    RPRÄ«µå°Ë»ç
  • rapid streptococcal antigen test
    ½Å¼Ó¿¬¼â±¸±ÕÇ׿ø½ÃÇè
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lysis, confluent
    ¿ÏÀü¿ë±Õ
  • lysis, osmotic
    »ïÅõ¾Ð¼º ¿ëÇØ
  • lysis-centrifugation system
    ¿ëÇØ-¿ø½É ºÐ¸®°è
  • tumor lysis syndrome
  • whole blood clot lysis time
    ÀüÇ÷Ç÷º´À¶ÇØ<--¿ëÇØ>½Ã°£
  • auxotrophic mutant
    ¿µ¾ç¿ä±¸¼º µ¹¿¬º¯ÀÌÁÖ
  • biochemical mutant
    »ýÈ­ÇÐÀû µ¹¿¬º¯ÀÌü(¡­ÔÍæÔܨì¶ô÷).
  • biochemical mutant
    »ýÈ­ÇÐÀû º¯ÀÌÁ¾(¡­Ü¨ì¶ðþ).
  • cold adapted mutant
    ÇÑ·©ÀûÀÀ µ¹¿¬º¯ÀÌü
  • conditional lethal mutant
    Á¶°ÇÄ¡»ç µ¹¿¬º¯ÀÌÁÖ
  • deletion mutant
    °á¼ÕÇüµ¹¿¬º¯ÀÌÁÖ
  • host-range mutant
    ¼÷ÁÖ¹üÀ§º¯ÀÌÁÖ
  • leaky mutant
    ´©Ãâµ¹¿¬º¯À̱Õ(¡­ÔÍæ× Ü¨ì¶Ð¶).
  • lethal mutant, conditional
    Á¶°ÇÄ¡»ç µ¹¿¬º¯ÀÌÁÖ
  • morphological mutant
    ÇüÅÂ(µ¹¿¬)º¯À̱Õ(ÁÖ)(û¡÷¾ÔÍæÔܨì¶Ð¶ñ»).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • biochemical mutant
    »ýÈ­ÇÐÀû(ßæûùùÊîÜ) º¯ÀÌÁ¾(ܨì¶ðú)
  • cofactor-requiring mutant
    º¸(Á¶)ÀÎÀڿ䱸 º¯ÀÌü(ÜÍ(ð¾)ì×í­é©Ï´Ü¨ì¶ô÷)
  • cold-sensitive mutant
    ³Ã¹Î°¨ º¯ÀÌü(Ò²ÚÂÊïܨì¶ô÷)
  • conditional lethal mutant
    Á¶°ÇºÎ Ä¡»çº¯ÀÌü(ðÉËìݾöÈÞÝܨì¶ô÷)
  • conditional mutant
    Á¶°ÇºÎ º¯ÀÌü(ðÉËìݾܨì¶ô÷)
  • cryptic mutant
    ÀáÀç º¯ÀÌü(íÖî¤Ü¨ì¶ô÷)
  • deficiency mutant
    "°áÇÌ º¯ÀÌü(ÌÀù¹Ü¨ì¶ô÷), (ÔÒ) auxotroph"
  • DNA-arrest mutant
    DNAÁ¤Áö(ïÎò­) º¯ÀÌü(ܨì¶ô÷)
  • DNA-delay mutant
    DNAÁöü º¯ÀÌü(òÀôòܨì¶ô÷)
  • DNA-negative mutant
    ¹«(Ùí)DNA º¯ÀÌü(ܨì¶ô÷)
  • dual-effect mutant
    ÀÌÁßÈ¿°ú º¯ÀÌü(ì£ñìüùÍýܨì¶ô÷)
  • host-range mutant
    ¼÷ÁÖ¹üÀ§ º¯ÀÌÁÖ(âÖñ«ÛôêÌܨì¶ñ»)
  • leaky mutant
    ´©Ã⺯ÀÌü(שõóܨì¶ô÷)
  • maturation-defective mutant
    ¼º¼÷°áÇÔ º¯ÀÌÁ¾(à÷âÙÌÀùèܨì¶ðú)
  • mutant
    "º¯ÀÌü(ܨì¶ô÷), º¯ÀÌÁÖ(ܨì¶ñÁ), º¯ÀÌÇü(ܨì¶úþ), º¯ÀÌÁ¾(ܨì¶ðú)"
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RSI rapid-sequence induction; rapid sequence intubation; repetition strain injury
ELT Euglobulin Lysis Time
ATLS acute tumor lysis syndrome; advanced trauma life support
BLT bleeding time; blood-clot lysis time; blood test
CLI complement lysis inhibitor; corpus luteum insufficiency
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MASA Mutant allele specific amplification
MFs Mutant frequencies
MF Mutant frequency
TLS Tumor Lysis Syndrome
CML cell mediated lysis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • rapid eye movement sleep
    ½Å¼Ó ¾È±¸¿îµ¿ ¼ö¸é, REM ¼ö¸é
    ½É¹Úµ¿, È£Èí ¼ö, Ç÷¾ÐÀÇ ½ÉÇÑ Áõ°¡, ±×¸®°í ºü¸¥ ¾È±¸ ¿îµ¿ ±â°£, ±Ù¿¬Ãà
  • rapid fiber
    ¼Ó¼¶À¯
  • rapid muscle
    ¼Ó±Ù
  • rapid processing chemical
    ±Þ¼Ó Çö»ó ¾à
  • rapid serum amylase test
    ±Þ¼Ó Ç÷û ¾Æ¹Ð·¹À̽º ½ÃÇè
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
active mutant A mutant with overt phenotypic expression.
(05 Mar 2000)
amber mutant A mutant with a mutation resulting in a UAG codon.
(05 Mar 2000)
auxotrophic mutant Mutant with a nutritional requirement not present in the wild type organism.
Synonym: defective organism, deficiency mutant.
(05 Mar 2000)
gap mutant <molecular biology> A fruit fly of the genus Drosophila which is missing a number of adjacent segments because the segments failed to develop.
(09 Oct 1997)
rats, mutant strains Rats bearing mutant genes which are phenotypically expressed in the animals.
(12 Dec 1998)
virulent phage mutant A mutant of a phage that is unable to establish lysogeny.
(05 Mar 2000)
relaxed mutant A mutant bacterium that continues to synthesise RNA in a medium that lackscertain nutrients or amino acids which that sort of bacterium normallyneeds present before it can make RNA.
(09 Oct 1997)
ced mutant <organism> Giant multinucleate fresh water amoeba (up to 5mm long) much used for studies on the mechanism of cell locomotion.
(18 Nov 1997)
cell division cycle mutant A yeast cell which has cell division cycle genes that have mutated to become sensitive to temperature, at certain temperatures (usually high ones), various parts of the normal yeast cell cycle become abnormal, and in some strains the yeast cell does not survive at all.
(09 Oct 1997)
petite mutant <molecular biology, organism> A class of yeast mutants, most studied in Saccharomyces cerevisiae. Mutants grow slowly and rely on anaerobic respiration: mitochondria, although present, have reduced cristae and are functionally defective (termed promitochondria). There are three types of petite mutant:
(i) Segregational mutants that show Mendelian behaviour and result from mutations in mitochondrial genes located in the nucleus.
(ii) Neutral petites, which are recessive genotypes and result from the complete absence of mitochondrial DNA.
(iii) Suppressive petites, in which most of the mitchondrial DNA is lost (60-99%), though what remains is often amplified.
(06 Oct 1997)
mice, mutant strains Mice bearing mutant genes which are phenotypically expressed in the animals.
(12 Dec 1998)
minute mutant <genetics, molecular biology> A class of recessive lethal mutants of Drosophila The heterozygotes grow more slowly, are smaller and less fertile than the wild type flies. There are about 40 loci that produce minute mutants.
(18 Nov 1997)
cold-sensitive mutant A mutant that is defective at low temperature but functional at normal temperature.
Compare: temperature-sensitive mutant.
(05 Mar 2000)
conditional-lethal mutant A viral mutant that can replicate under some (permissive) conditions but not under other (restrictive or nonpermissive) conditions, the parent (wild type) strain being able to replicate under both conditions.
See: suppressor-sensitive mutant, temperature-sensitive mutant.
Synonym: conditional-lethal mutant.
(05 Mar 2000)
conditionally lethal mutant A viral mutant that can replicate under some (permissive) conditions but not under other (restrictive or nonpermissive) conditions, the parent (wild type) strain being able to replicate under both conditions.
See: suppressor-sensitive mutant, temperature-sensitive mutant.
Synonym: conditional-lethal mutant.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á